Jason A. Okazaki - 16 Feb 2023 Form 4 Insider Report for ASSEMBLY BIOSCIENCES, INC. (ASMB)

Role: CEO and President, Director
Signature: /s/ John O. Gunderson, as Attorney-in-Fact
Issuer symbol: ASMB
Transactions as of: 16 Feb 2023
Net transactions value: $0
Form type: 4
Filing time: 17 Feb 2023, 15:05:41 UTC
Previous filing: 03 Aug 2022
Next filing: 28 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ASMB	Common Stock	Award	$0	+12,500	+13%	$0.000000	107,114	16 Feb 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock issuable under a performance-based restricted stock unit award dated August 1, 2022. On February 16, 2023, a performance-based vesting condition was achieved with respect to these shares of common stock, which remain subject to time-based vesting and will vest in two equal installments, assuming continuous service on each vesting date, as follows: August 1, 2023 and August 1, 2024.

Content

Represents shares of common stock issuable under a performance-based restricted stock unit award dated August 1, 2022. On February 16, 2023, a performance-based vesting condition was achieved with respect to these shares of common stock, which remain subject to time-based vesting and will vest in two equal installments, assuming continuous service on each vesting date, as follows: August 1, 2023 and August 1, 2024.